STAT+: Pharmalittle: Appellate judges appear skeptical of FDA decisions on abortion pill; FTC widens probe into PBMs
Top of the morning to you, and a fine one it is. Once again, crystal…
Category: pharmalittle
STAT+: Pharmalittle: FTC suit over Amgen spotlights ‘bundling’ deals with insurers; FDA staff says Pfizer RSV vaccine is effective
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: Pharmalittle: FTC may sue to block Amgen deal for Horizon; Supreme Court declines Teva appeal on skinny labeling
Oh, what a beautiful morning! Pardon the cliché, but crystal clear blue skies and deliciously…
STAT+: Pharmalittle: FDA OKs new kind of drug to treat hot flashes; Alzheimer’s drug could cost Medicare up to $5 billion a year
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: U.S. Senate committee passes PBM bills; Pfizer CEO predicts pharma will sue over Medicare price negotiations
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: FDA panel recommends first OTC birth control pill; Senate hearing on insulin costs satisfies no one
Hello, everyone, and how are you today? We are doing just fine, thank you, as…
STAT+: Pharmalittle: Gilead wins lawsuit against HHS over HIV pill patents; most Americans say abortion pill should remain on the market
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
STAT+: Pharmalittle: FDA panel to review over-the-counter birth control pill; Alzheimer’s drugs may lead to haves and have-nots
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Pfizer and Valneva delay application for Lyme vaccine; Moderna adjusts price for Covid-19 shot
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: FDA OKs first RSV vaccine for older adults; Lilly Alzheimer’s data puts pressure on Medicare
Rise and shine, another busy day is on the way. We can tell by the…
STAT+: Pharmalittle: Lilly’s Alzheimer’s drug slowed cognitive decline; most EU countries back plan to push production of key drugs
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: Senate PBM reform bill delays effective date; Gilead and HHS square off in court over HIV patents
Good morning, everyone, and how are you today? Steely skies are hovering this morning over…
STAT+: Pharmalittle: More biotechs are betting on obesity; Pfizer RSV vaccine faces hurdles in low-income countries
Good morning, everyone, and nice to see you again after a week-long respite in which…
.jpg)
STAT+: Pharmalittle: Amgen ends two lupus programs; Illumina sequencers have security vulnerability
Hello and happy Friday, with STAT reporter Andrew Joseph here steering the ship in place…
STAT+: Pharmalittle: Lilly’s Mounjaro helped people lose 15.7% of body weight; Sanofi earnings boosted by Dupixent
Good morning everyone, from STAT reporter Andrew Joseph here filling in for Ed. Or, if…
STAT+: Pharmalittle: EU unveils sweeping pharma reforms; new eye drug helps Roche beat the street
Hello, everyone. Damian Garde here, filling in for Ed Silverman once more as the working…
STAT+: Pharmalittle: Novartis boosts its sales and profit outlook; Biogen trims its drug pipeline
Good morning, one and all. Damian Garde here, filling in for Ed Silverman on an…
STAT+: Pharmalittle: Weight-loss drug makers lobby Congress for Medicare coverage; Europe braces for new pharma legislation
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: GSK manufacturing workers in the U.K. to strike in May; weight-loss drugs prompt strange dreams
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Pharmalittle: GSK will buy Bellus Health for $2 billion; FDA inspectors are leaving faster than they can be replaced
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Pharmalittle: Merck to acquire Prometheus Biosciences for $10.8 billion; mRNA cancer vaccine reduces melanoma relapse
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Telehealth abortion providers are scrambling; Express Scripts launches new pricing plan amid PBM scrutiny
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Appeals court allows access to abortion pill, but with restrictions; FDA official intervened on behalf of Sarepta gene therapy
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT+: Pharmalittle: Where is PhRMA in the abortion pill debate? Most late-stage MS drug trials were never published
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Pharmalittle: Pharma execs call for reversal of abortion pill ruling; U.S. to spend $5 billion to speed Covid-19 treatments
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Pharmalittle: Abortion pill ruling could threaten FDA approval authority; Lilly CEO warns EU pharma legislation will hurt innovation
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Genentech finds no evidence of fraud in paper by former top exec; FDA withdraws approval for premature-birth drug
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Weight-loss drug ads pose new oversight challenge; will the new Bayer CEO split the company?
Rise and shine, another busy day is on the way. We can tell because the…
STAT+: Pharmalittle: J&J agrees to settle talcum powder claims for $8.9 billion; FDA authorizes new severe-Covid therapy
Good morning! Jason Mast here, filling in for Ed on this fine Passover eve. Every…
STAT+: Pharmalittle: A ‘King Kong’ of weight-loss drugs is looming; FTC orders Illumina to divest Grail
Hello, everyone, and how are you today? We are doing just fine, thank you, since…
STAT+: Pharmalittle: Judge blocks required ACA coverage for preventive care; Supreme Court urged to review skinny label case
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: FDA approves over-the-counter Narcan; J&J exits the race for the first RSV vaccine
Rise and shine, another busy day is on the way. We can tell because the…
STAT+: Pharmalittle: WHO may add obesity drugs to essential medicines list; monkey shortage may delay drug development
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Pharmalittle: Ohio attorney general accuses PBMs of price fixing; how cost-effectiveness fight could hobble drug price negotiations
Top of the morning to you. Steely gray skies are hovering over the Pharmalot campus…
STAT+: Pharmalittle: FDA proposes more rigorous cancer drug trials for accelerated approval; insurers not covering obesity meds for kids
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: EU delays pharma legislation again; India cancels license for maker of cough syrup linked to deaths
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: FDA panel backs conditional approval for Biogen ALS drug; pharma fights tactic for lowering specialty med costs
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Pharmalittle: FDA official wants to use accelerated approval for gene therapies; pharma asks Biden for tax breaks in the semiconductor package
Top of the morning to you, and a fine one it is. A bright, shiny…
STAT+: Pharmalittle: Manufacturers say bird flu shots for humans can be made quickly; obesity guidelines for children disappoint
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Alzheimer’s group starts lobbying for Medicare to cover new drug; U.S. judge seems sympathetic to abortion-pill challenge
Good morning, everyone, and how are you today? Hazy skies are enveloping the frosty Pharmalot…
STAT+: Pharmalittle: Biden administration to fine drugmakers for price hikes on 27 meds; Dems push pharmacy chains over access to abortion pill
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: Novo to cut some insulin prices by up to 75%; Veterans Administration to cover new Alzheimer’s treatment
Rise and shine, everyone, another busy day is on the way. The Pharmalot campus, in…
STAT+: Pharmalittle: Biogen exec who quarterbacked Aduhelm leaves; Pfizer to buy Seagen for $43 billion
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: FDA head wants to get rid of advisory panel votes; premature-birth drug is finally withdrawn
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
.jpg)
STAT+: Pharmalittle: Biden proposes expanding Medicare drug-price negotiation; Weight Watchers moves into obesity drug market
Top of the morning to you, and a fine one it is. Shiny and clear…
STAT+: Pharmalittle: ALS Association and its chapters battle over money and priorities; eye drops recalled over links to drug-resistant infections
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: GSK CEO warns U.K. pharma industry is at a ‘tipping point’; Gavi tussles with vaccine makers over refunds
Top of the morning to you. And a fine one it is. Sunny skies and…
STAT+: Pharmalittle: Pfizer projects lower revenue from Covid-19 products; Medicare eyes policy for paying less for accelerated-approval drugs
Top of the morning to you. The middle of the week is upon us and,…
STAT+: Pharmalittle: Amgen pricing for Humira biosimilar may not help patients; pharma wins court battle over drug discount program
Hello, everyone, and how are you this morning? We are just fine, thank you, although…
STAT+: Pharmalittle: Pfizer is scolded by U.K. industry group over CEO’s remarks on vaccination; Amgen to lay off 300 U.S. employees
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…